| Bioactivity | BCR-ABL1-IN-1 is a potent, orally active, and specific inhibitor of ABL kinase. BCR-ABL1-IN-1 has potential for elucidating the role of ABL kinases in the brain in non-clinical studies[1]. |
| Name | BCR-ABL1-IN-1 |
| CAS | 1488090-21-6 |
| Formula | C18H12F3N3O2 |
| Molar Mass | 359.30 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Manley PW, et al. A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood-brain barrier. Bioorg Med Chem Lett. 2022;59:128577. |
BCR-ABL1-IN-1
CAS: 1488090-21-6 F: C18H12F3N3O2 W: 359.30
BCR-ABL1-IN-1 is a potent, orally active, and specific inhibitor of ABL kinase. BCR-ABL1-IN-1 has potential for elucidat
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.